HDAC inhibitors act with 5-aza-2'-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells.
5-Aza-2'-deoxycytidine (5-aza-CdR) is used extensively as a demethylating agent and acts in concert with histone deacetylase inhibitors (HDACI) to induce apoptosis or inhibition of cell proliferation in human cancer cells. Whether the action of 5-aza-CdR in this synergistic effect results from...
Enregistré dans:
Auteurs principaux: | , , , , , , , , , , , , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2008
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/bb0948831c134fafa74209741842ac68 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|